Propranolol vs atenolol.
Two properties separate these drugs, and each one generates a different half of the clinical picture. Learn which property does what and you can predict the answer to any question about the pair without remembering a single side effect.
Propranolol is non-selective and lipophilic; atenolol is beta-1 selective and hydrophilic. Selectivity decides the airway risk, because only propranolol blocks the beta-2 receptors that keep bronchi open, and lipid solubility decides the central side effects, because only propranolol crosses into the brain in quantity.
Propranolol vs Atenolol at a glance
| Property | Propranolol | Atenolol |
|---|---|---|
| Receptor selectivity | Non-selective, blocks beta-1 and beta-2 | Beta-1 selective at usual doses |
| Lipid solubility | Lipophilic | Hydrophilic |
| CNS penetration | Substantial | Minimal |
| Asthma | Contraindicated | Caution, but usable where indicated |
| Clearance | Hepatic, with extensive first pass | Renal, largely unchanged |
| Non-cardiac uses | Tremor, migraine prophylaxis, thyrotoxicosis, anxiety | Few |
What selectivity actually buys you
Beta-2 receptors relax bronchial smooth muscle, so blocking them opposes bronchodilation. Propranolol does this and atenolol largely does not, which is the entire reason cardioselective agents were developed. The important qualification is that selectivity is relative rather than absolute: at high enough doses atenolol blocks beta-2 as well, so it is safer in airway disease rather than safe.
What lipid solubility explains
Propranolol crosses the blood-brain barrier readily, which produces both a useful effect and an unwanted one. The useful one is genuine central activity in migraine prophylaxis and in the physical symptoms of anxiety. The unwanted one is vivid dreams, nightmares and fatigue. Atenolol, being hydrophilic, stays largely peripheral, which makes it duller and better tolerated centrally.
Why clearance route matters in exams
Propranolol is hepatically cleared with a large first pass effect, so liver disease and enzyme interactions alter its levels. Atenolol is renally cleared and largely unmetabolised, so renal impairment is what changes its dosing. A question that mentions kidney or liver function is usually testing this rather than anything about beta receptors.
Which one would the question pick?
Exams rarely ask what a drug does. They describe a patient and ask which of the two you would choose, so the scenarios below matter more than either drug monograph.
| Scenario | Pick | Why |
|---|---|---|
| Coexisting asthma or COPD | Atenolol | Beta-1 selectivity spares the airway, with caution at higher doses. |
| Essential tremor or migraine prophylaxis | Propranolol | Central penetration is required for the effect. |
| Significant renal impairment | Propranolol | Hepatic clearance avoids accumulation. |
| Patient troubled by nightmares | Atenolol | Hydrophilic, so minimal CNS penetration. |
Traps that catch people on this pair
Treating selectivity as absolute
A cardioselective agent at a high dose blocks beta-2 too. Exams test this by pairing a high dose with an asthmatic patient.
Forgetting both mask hypoglycaemia
The masking effect is beta-1 and beta-2 mediated, so selectivity does not remove it. Sweating remains in both cases because it is cholinergic.
Common questions
What is the difference between propranolol and atenolol?
Propranolol is non-selective and lipophilic; atenolol is beta-1 selective and hydrophilic. Selectivity decides the airway risk, because only propranolol blocks the beta-2 receptors that keep bronchi open, and lipid solubility decides the central side effects, because only propranolol crosses into the brain in quantity.
What is the main difference between propranolol and atenolol?
Propranolol is non-selective and lipid soluble; atenolol is beta-1 selective and water soluble. Selectivity determines the airway risk and lipid solubility determines the central nervous system effects.
Why is propranolol avoided in asthma?
It blocks beta-2 receptors in bronchial smooth muscle, removing the signal that keeps airways dilated, which can precipitate bronchospasm.
Which beta blocker causes nightmares?
Propranolol, because it is lipophilic and crosses into the brain. Atenolol is hydrophilic and largely stays peripheral, so central effects are uncommon.
Go deeper on the mechanism
A comparison only sticks once the shared mechanism underneath it does, because what separates two drugs is always a variation on something they have in common.
- Beta blockers — the class both drugs belong to
- Cardiovascular pharmacology questions — test the distinction under time
- Selective versus non-selective beta blockers
Other comparisons
Heparin vs Warfarin · Warfarin vs DOACs · Unfractionated heparin vs Enoxaparin · Metoprolol vs Atenolol · Amlodipine vs Nifedipine · Furosemide vs Bendroflumethiazide · Spironolactone vs Eplerenone · Simvastatin vs Atorvastatin · All comparisons
Study aid only. This page is written for learning and examination practice. It is not medical advice, not clinical decision support, and must never be used to make a decision about a real patient. Always verify against your local formulary, the product literature and a qualified pharmacist. See our medical disclaimer.
Two drugs, one property apart.
PharmBit teaches the shared mechanism first, then the single difference that splits the pair. Free download, no credit card.
Free to download. 7-day Pro trial. Cancel anytime.